Neuromagen Pharma

Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules that activate telomerase reverse transcriptase (TERT) — an enzyme playing a major role in aging-related diseases and cellular senescence. Neuromagen's pipeline includes drugs for treating neurodegenerative diseases such as ALS and Alzheimer’s disease, Type 1 diabetes, fertility issues, and cardiovascular diseases.